BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 12771043)

  • 1. Molecular profiling of hepatocellular carcinomas developing spontaneously in acyl-CoA oxidase deficient mice: comparison with liver tumors induced in wild-type mice by a peroxisome proliferator and a genotoxic carcinogen.
    Meyer K; Lee JS; Dyck PA; Cao WQ; Rao MS; Thorgeirsson SS; Reddy JK
    Carcinogenesis; 2003 May; 24(5):975-84. PubMed ID: 12771043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of peroxisome proliferator-activated receptor alpha, and PPARalpha regulated genes in spontaneously developed hepatocellular carcinomas in fatty acyl-CoA oxidase null mice.
    Meyer K; Jia Y; Cao WQ; Kashireddy P; Rao MS
    Int J Oncol; 2002 Dec; 21(6):1175-80. PubMed ID: 12429965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor alpha-responsive genes induced in the newborn but not prenatal liver of peroxisomal fatty acyl-CoA oxidase null mice.
    Cook WS; Jain S; Jia Y; Cao WQ; Yeldandi AV; Reddy JK; Rao MS
    Exp Cell Res; 2001 Aug; 268(1):70-6. PubMed ID: 11461119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis.
    Yeldandi AV; Rao MS; Reddy JK
    Mutat Res; 2000 Mar; 448(2):159-77. PubMed ID: 10725470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of spontaneous peroxisome proliferation in enoyl-CoA Hydratase/L-3-hydroxyacyl-CoA dehydrogenase-deficient mouse liver. Further support for the role of fatty acyl CoA oxidase in PPARalpha ligand metabolism.
    Qi C; Zhu Y; Pan J; Usuda N; Maeda N; Yeldandi AV; Rao MS; Hashimoto T; Reddy JK
    J Biol Chem; 1999 May; 274(22):15775-80. PubMed ID: 10336479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisomal and mitochondrial fatty acid beta-oxidation in mice nullizygous for both peroxisome proliferator-activated receptor alpha and peroxisomal fatty acyl-CoA oxidase. Genotype correlation with fatty liver phenotype.
    Hashimoto T; Fujita T; Usuda N; Cook W; Qi C; Peters JM; Gonzalez FJ; Yeldandi AV; Rao MS; Reddy JK
    J Biol Chem; 1999 Jul; 274(27):19228-36. PubMed ID: 10383430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase. Implications for peroxisome proliferator-activated receptor alpha natural ligand metabolism.
    Fan CY; Pan J; Usuda N; Yeldandi AV; Rao MS; Reddy JK
    J Biol Chem; 1998 Jun; 273(25):15639-45. PubMed ID: 9624157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel peroxisome proliferator-activated receptor alpha (PPARalpha) target genes in mouse liver using cDNA microarray analysis.
    Cherkaoui-Malki M; Meyer K; Cao WQ; Latruffe N; Yeldandi AV; Rao MS; Bradfield CA; Reddy JK
    Gene Expr; 2001; 9(6):291-304. PubMed ID: 11764000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor alpha-dependent induction of cell surface antigen Ly-6D gene in the mouse liver.
    Dadras SS; Cook WS; Yeldandi AV; Cao WQ; Rao MS; Wang Z; Reddy JK
    Gene Expr; 2001; 9(4-5):173-81. PubMed ID: 11444527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of peroxisome proliferator-activated receptor alpha in rat Fao cells and stimulation by ciprofibrate.
    Passilly P; Schohn H; Jannin B; Cherkaoui Malki M; Boscoboinik D; Dauça M; Latruffe N
    Biochem Pharmacol; 1999 Sep; 58(6):1001-8. PubMed ID: 10509752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein profiling of mouse livers with peroxisome proliferator-activated receptor alpha activation.
    Chu R; Lim H; Brumfield L; Liu H; Herring C; Ulintz P; Reddy JK; Davison M
    Mol Cell Biol; 2004 Jul; 24(14):6288-97. PubMed ID: 15226431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated basal expression of liver peroxisomal beta-oxidation enzymes and CYP4A microsomal fatty acid omega-hydroxylase in STAT5b(-/-) mice: cross-talk in vivo between peroxisome proliferator-activated receptor and signal transducer and activator of transcription signaling pathways.
    Zhou YC; Davey HW; McLachlan MJ; Xie T; Waxman DJ
    Toxicol Appl Pharmacol; 2002 Jul; 182(1):1-10. PubMed ID: 12127257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of peroxisome proliferator-activated receptor alpha activation on pathways contributing to cholesterol homeostasis in rat hepatocytes.
    Le Jossic-Corcos C; Duclos S; Ramirez LC; Zaghini I; Chevillard G; Martin P; Pineau T; Bournot P
    Biochim Biophys Acta; 2004 Jul; 1683(1-3):49-58. PubMed ID: 15238219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of peroxisome proliferator-activated receptor-alpha (PPARalpha)-regulated genes in liver in the absence of peroxisome proliferation in mice deficient in both L- and D-forms of enoyl-CoA hydratase/dehydrogenase enzymes of peroxisomal beta-oxidation system.
    Jia Y; Qi C; Zhang Z; Hashimoto T; Rao MS; Huyghe S; Suzuki Y; Van Veldhoven PP; Baes M; Reddy JK
    J Biol Chem; 2003 Nov; 278(47):47232-9. PubMed ID: 14500732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver gene expression in rats in response to the peroxisome proliferator-activated receptor-alpha agonist ciprofibrate.
    Yadetie F; Laegreid A; Bakke I; Kusnierczyk W; Komorowski J; Waldum HL; Sandvik AK
    Physiol Genomics; 2003 Sep; 15(1):9-19. PubMed ID: 12851464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyunsaturated fatty acid suppression of hepatic fatty acid synthase and S14 gene expression does not require peroxisome proliferator-activated receptor alpha.
    Ren B; Thelen AP; Peters JM; Gonzalez FJ; Jump DB
    J Biol Chem; 1997 Oct; 272(43):26827-32. PubMed ID: 9341113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of peroxisome proliferation by perfluorooctanoic acid and endogenous fatty acids.
    Intrasuksri U; Rangwala SM; O'Brien M; Noonan DJ; Feller DR
    Gen Pharmacol; 1998 Aug; 31(2):187-97. PubMed ID: 9688458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in the formation of PPARalpha-RXR/acoPPRE complexes between responsive and nonresponsive species upon fibrate administration.
    Rodríguez C; Noé V; Cabrero A; Ciudad CJ; Laguna JC
    Mol Pharmacol; 2000 Jul; 58(1):185-93. PubMed ID: 10860941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The peroxisome proliferator response element of the gene encoding the peroxisomal beta-oxidation enzyme enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase is a target for constitutive androstane receptor beta/9-cis-retinoic acid receptor-mediated transactivation.
    Kassam A; Winrow CJ; Fernandez-Rachubinski F; Capone JP; Rachubinski RA
    J Biol Chem; 2000 Feb; 275(6):4345-50. PubMed ID: 10660604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-response relationships of hepatic acyl-CoA oxidase and catalase activity and liver mitogenesis induced by the peroxisome proliferator ciprofibrate in C57BL/6N and BALB/c mice.
    Budroe JD; Umemura T; Angeloff K; Williams GM
    Toxicol Appl Pharmacol; 1992 Apr; 113(2):192-8. PubMed ID: 1561628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.